BVS News and Press, Bioventus Inc. From 02/09/22

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements Fourth Quarter 2021 Financial Results to be Announced in March PR Newswire DALLAS , Feb. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life s...

DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary revenue results for the fourth quarter and full-year 2021. Prelim...

DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 40 th Annual J.P. Morgan Healthcare Conference via webcast on Wednesday, Janu...

DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of Michelle McMurry-Heath, MD, PhD, to the Company’s Board of ...

Bioventus (NASDAQ:BVS) perks up 3% premarket after announcing that the FDA has granted 510(k) clearance for its neXus BoneScalpel Access handpiece. The neXus system combines all the features of soft and hard (e.g. bone) tissue removal into a single fully integrated of...

DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Company&#x...

MEMPHIS, Tenn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has signed a lease agreement to double its current operations and manufacturing space and relocat...

Bioventus (BVS -0.7%) announces that Greg Anglum is transitioning from his role as seniorVP and CFO to pursue other career opportunities. To ensure a smooth transition, Mr. Anglum will remain in his current role until a successor is named. The company has begin search...

DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today announced that Greg Anglum is transitioning from his role as Senior Vice President and Chief Financial Officer (CFO) to p...

Bioventus Inc. (BVS) Q3 2021 Earnings Conference Call November 9, 2021 08:30 ET Company Participants Dave Crawford - Vice President of Investor Relations Ken Reali - Co-Founder & Chief Executive Officer Greg Anglum - Chief Financial Officer Conference Call Participants Kyle Rose - Canacco...